Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
With this clinical trial the investigators will analyze whether the rate of pregnancy losses
before the 24th week of gestation can be reduced by dalteparin treatment in habitual
aborters.
Phase:
Phase 3
Details
Lead Sponsor:
University of Jena
Treatments:
alpha-Tocopherol Dalteparin Folic Acid Heparin Heparin, Low-Molecular-Weight Pyridoxine Riboflavin Thiamine Tinzaparin Tocopherols Tocotrienols Vitamin B 12 Vitamin B Complex Vitamin E